FDA clears Candela's psoriasis treatment laser:
This article was originally published in Clinica
Executive Summary
Candela has received US FDA 510(k) clearance to market its pulsed dye laser for the treatment of psoriasis, the second most common skin disorder in the US. The Wayland, Massachusetts company expects sales of the device to start later in the year.